Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 Diabetes (WheyGLP-1)

This study has been completed.
Information provided by (Responsible Party):
Daniela Jakubowicz, Tel Aviv University Identifier:
First received: April 3, 2012
Last updated: March 27, 2014
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):